We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 22 JUNE 2017
Sandoz v. Amgen Supreme Court Decision

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Contributor

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP is one of the world’s largest firms focusing on...
View firm profileBelow, a divided Federal Circuit panel held that: (1) a biosimilar applicant is not required to provide its application and manufacturing information to the Reference Product Sponsor (RPS)
United StatesIntellectual Property









